Nasdaq Gains Over 100 Points, Posts Weekly Gain: Investor Sentiment Improves Slightly, But Greed Index Remains in ‘Fear’ Zone
Market sentiment improved slightly but stayed in Fear; stocks were mixed, the Dow had its worst week since March.
Stocks · News reference
Accenture, Abivax and 3 Stocks to Watch Heading Into Monday
Stocks in focus: Abivax, Marygold and Neuphoria report losses; Accenture partners with Anthropic, while Lobo Technologies posts H1 growth.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Abivax will report H1 earnings Sept. 21; analysts expect a $1.08 loss/share and $1.86M revenue.
This Amer Sports Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Analysts initiate: Buy—Abivax ($155), Amer Sports ($42) and more
Accenture Rebounds After Friday Selloff as Anthropic Partnership Draws Attention
Accenture Anthropic Partnership lifts ACN shares as investors weigh AI safety plans, Faculty expertise and upcoming earnings.
Stock Market Today: S&P 500, Nasdaq 100 Futures Gain as Trump Issues Fresh Warning to Iran — MRVL, AAPL, ACN in Focus
U.S. stock futures advanced on Monday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Friday's mixed close.
Accenture shares are trading higher after the company announced a a partnership to establish a team of embedded evaluators at Anthropic.